by The global Bovine Mastitis Market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bovine Mastitis refers to inflammation of mammary gland in dairy cows. It is caused by bacterial infections that enter through teat canal and multiply in mammary gland tissue. Early detection and treatment of clinical mastitis helps maintain milk production and quality.
Market key trends:
One of the key trends in the bovine mastitis market is the increasing adoption of precision livestock farming technology. Precision livestock farming utilizes sensors, automated systems and IoT solutions to monitor cattle health and detect diseases like mastitis at an early stage. This technology helps farmers to prioritize treatment, improve cow comfort and optimize resource utilization. For example, DeLaval introduced an AI-based solution that uses computer vision to automatically detect mastitis from milk samples. Such precision farming solutions are gaining popularity among dairy farmers to curb losses due to mastitis.
Segment Analysis
The Bovine Mastitis Market is segmented by type, treatment, end user, and region. By type, the clinical mastitis segment dominated the market in 2023, accounting for around 65% share of the global bovine mastitis market revenue. Clinical mastitis is more prevalent among dairy cows and requires immediate treatment to prevent economic losses to dairy farmers.
Key Takeaways
The global bovine mastitis market size was valued at USD 1497.52 Mn in 2023. The market is expected to grow at a CAGR of 5.2% over the forecast period due to rising occurrences of mastitis infections among dairy cattle and increasing milk production.
Regional Analysis
North America emerged as the largest regional bovine mastitis market, accounting for over 30% of global revenue in 2023. The high demand for dairy products and prevalence of bovine mastitis in the US and Canada drive market growth. Europe and Asia Pacific are expected to witness high CAGRs owing to growing dairy industries and increasing awareness regarding bovine healthcare.
Key Players
Key players operating in the bovine mastitis market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd. Zoetis and Boehringer Ingelheim hold a significant share due to their widespread product portfolios and strong distribution networks globally.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
